Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
blue®m versus saline nasal spray after endoscopic sinonasal surgery
RBR-72mvv89Completed
- Sponsor
- Hospital IPO
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of BlueM and sodium chloride in chronic rhinosinusitis (CRS), Chronic pansinusitis, maxillary sinusitis and 1 more (2 arms), sponsored by Hospital IPO. Started Oct 2020; status: completed.
02
Drugs
BlueMsodium chloride
03
Conditions
chronic rhinosinusitis (CRS)Chronic pansinusitismaxillary sinusitischronic ethmoiditis
Beyond the preview
Go deeper on RBR-72mvv89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-72mvv89.